Clinician Investigator, Associate Professor Allergy and Clinical Immunology Unit, Mass General Research Institute

Associate Professor of Medicine Harvard Medical School

Associate Physician Allergy and Clinical Immunology Unit, Massachusetts General Hospital

MD Yale University School of Medicine 2009

MSc 2016

allergy and immunology; anti-bacterial agents; antibiotic allergies; antibiotic stewardship; cephalosporins; drug allergy; drug hypersensitivity; drug prescriptions; education; eosinophilia; exanthema; over-reported drug allergies; penicillins; skin tests; stevens-johnson syndrome; vancomycin

Kimberly Blumenthal, MD, MSc is an Allergist/Immunologist and clinical researcher at Massachusetts General Hospital and Associate Professor of Medicine at Harvard Medical School.  She is the Co-Director of the Clinical Epidemiology Research Center and Director of Research in the Center for Drug and Vaccine Allergy. Dr. Blumenthal performs drug and vaccine allergy research that uses methods of epidemiology, informatics, economics, decision science, and implementation science. Her research has been funded by the National Institute of Health, Agency for Healthcare Research and Quality, and foundations, including the American Academy of Allergy, Asthma, and Immunology Foundation and CRICO, the risk management foundation of Harvard Medical School. Dr. Blumenthal is internationally recognized for identifying the morbidity and mortality associated with unverified penicillin allergies and creating innovative approaches to the evaluation of penicillin and cephalosporin antibiotic allergies in diverse patient settings. Dr. Blumenthal has authored more than 170 peer-reviewed publications including leading high-impact manuscripts to publication in journals such as NEJM, Lancet, JAMA, and the BMJ.

Dr. Blumenthal graduated from Columbia University with a BA in Economics.  She studied medicine at Yale University School of Medicine, before training at the Massachusetts General Hospital for Internal Medicine and Allergy and Immunology. She completed a Master of Science in Clinical Epidemiology at the Harvard T.H. Chan School of Public Health in 2017.